📈 They will integrate **real-time monitoring capabilities** using Repligen’s MAVEN® platform.
🔍 This technology allows continuous tracking of glucose and lactate levels in bioreactors, improving nutrient testing efficiency.
⚙️ This partnership aims to optimize cell growth processes for advanced therapies, ensuring better development strategies.
Introduction:
This article discusses a strategic partnership between Repligen and Univercells Technologies aimed at enhancing the manufacturing efficiency of viral vectors and vaccines through the integration of real-time monitoring technologies. The collaboration primarily utilizes Repligen’s MAVEN® platform to ensure precise control over crucial growth parameters in biomanufacturing processes.
- Univercells Technologies has entered into a collaboration with Repligen to implement real-time monitoring in viral vector and vaccine biomanufacturing.
- The cooperation will utilize Repligen’s MAVEN® Real Time Glucose Control Platform for continuous monitoring of glucose and lactate levels.
- The MAVEN platform enables real-time insights into cellular metabolism, improving the optimization of nutrient media and feeding strategies during cell culture.
- Integration of MAVEN with scale-X bioreactors enhances data collection frequency, allowing for process adjustments every two minutes with up to 720 data points on glucose and lactate daily.
- Compatibility between the partnered technologies is deemed essential for the commercialization of advanced therapies, providing developers the capability to focus on creating optimal conditions for cell growth.
Conclusion:
The partnership between Repligen and Univercells Technologies represents a significant advancement in the field of biomanufacturing by leveraging real-time analytical techniques. The integration of the MAVEN platform within scale-X bioreactors not only streamlines the manufacturing process but also enhances the precision of operational data, crucial for the effective development of therapeutic products. This initiative could have far-reaching implications for the efficiency and efficacy of future vaccine and viral vector production.
